PAPOTTI, BIANCA
 Distribuzione geografica
Continente #
NA - Nord America 1.816
AS - Asia 1.688
EU - Europa 1.054
SA - Sud America 243
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 75
OC - Oceania 2
Totale 4.962
Nazione #
US - Stati Uniti d'America 1.752
SG - Singapore 579
IT - Italia 474
VN - Vietnam 330
CN - Cina 314
BR - Brasile 182
HK - Hong Kong 139
BD - Bangladesh 93
IE - Irlanda 92
DE - Germania 82
FR - Francia 71
ZA - Sudafrica 58
RU - Federazione Russa 53
IN - India 47
SE - Svezia 43
AT - Austria 42
GB - Regno Unito 42
NL - Olanda 40
JP - Giappone 31
CA - Canada 28
AR - Argentina 27
KR - Corea 26
ES - Italia 21
IQ - Iraq 20
MX - Messico 20
TR - Turchia 20
FI - Finlandia 19
ID - Indonesia 12
LU - Lussemburgo 12
PL - Polonia 11
LT - Lituania 10
CO - Colombia 9
PH - Filippine 9
PK - Pakistan 9
BE - Belgio 8
TH - Thailandia 7
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
IL - Israele 5
MY - Malesia 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
SA - Arabia Saudita 4
UA - Ucraina 4
CI - Costa d'Avorio 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
VE - Venezuela 3
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
ET - Etiopia 1
EU - Europa 1
IM - Isola di Man 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MQ - Martinica 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 4.886
Città #
Singapore 336
Ashburn 260
Dallas 242
San Jose 212
Hong Kong 124
Parma 121
Council Bluffs 116
Santa Clara 107
Dublin 93
Ho Chi Minh City 92
Hanoi 82
Boardman 75
Beijing 65
Chandler 62
Hefei 54
Johannesburg 54
Chicago 52
Los Angeles 50
New York 45
Shanghai 40
Lauterbourg 32
Milan 29
Munich 29
Hillsboro 26
Vienna 26
Tokyo 24
Seoul 23
Rome 18
Frankfurt am Main 17
Marseille 17
São Paulo 17
Moscow 16
Bologna 15
Haiphong 14
Modena 13
Da Nang 12
Atlanta 11
Brooklyn 11
Denver 11
Seattle 11
Bremen 10
Buffalo 10
London 10
Manchester 10
Montreal 10
Nuremberg 10
Orem 10
Turku 10
Warsaw 10
Bengaluru 9
Genoa 9
Helsinki 9
Istanbul 9
Phoenix 9
Poplar 9
San Francisco 9
Chennai 8
Mexico City 8
Toronto 8
Columbus 7
Formigine 7
Jakarta 7
Luxembourg 7
Mumbai 7
Naples 7
Piacenza 7
Princeton 7
Pune 7
Reggio Emilia 7
Wilmington 7
Ann Arbor 6
Dalmine 6
Graz 6
Guangzhou 6
Madrid 6
Memphis 6
Poviglio 6
Verona 6
Baghdad 5
Biên Hòa 5
Brno 5
Castello Molina di Fiemme 5
Charleroi 5
Como 5
Florence 5
Hải Dương 5
Ninh Bình 5
Pittsburgh 5
Tashkent 5
Amsterdam 4
Ankara 4
Bangkok 4
Belo Horizonte 4
Canoas 4
Decatur 4
Houston 4
New Delhi 4
Padua 4
Paris 4
Rio de Janeiro 4
Totale 3.055
Nome #
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 299
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 251
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 207
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 177
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 174
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 169
Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis 167
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 165
HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals 164
Drug-drug interactions in polypharmacy patients: The impact of renal impairment 153
Serum cholesterol loading capacity on macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients 151
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 143
Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: Molecular mechanisms and therapeutic implications 137
HDL Proteome and Alzheimer's Disease: Evidence of a Link. 132
A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus 126
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis 126
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease 123
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 114
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease 106
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 103
Hdl in covid-19 patients: Evidence from an italian cross-sectional study 101
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis 100
“Investigating PCSK9 inhibition as potential strategy in Alzheimer’s disease” 99
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 98
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefence 97
Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis 93
Bioactive Alkaloids from Nepalese Corydalis chaerophylla D.C. Acting on the Regulation of PCSK9 and LDL-R In Vitro 92
Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism 86
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis 85
Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line 83
Investigating PCSK9 as a therapeutic target in Alzheimer's disease: evidence from patient-derived astrocytes 70
RELATIONSHIP BETWEEN CHOLESTEROL ACCUMULATION AND CELLULAR SENESCENCE IN AN IN VITRO MODEL OF HUMAN MACROPHAGE: POTENTIAL PROTECTIVE EFFECTS OF RESVERATROL 62
"Effect of natural and synthetic PCSK9 inhibitors on Alzheimer’s disease-related parameters in human cerebral cell models" 60
Relationship Between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Human Macrophages 60
In vitro and in vivo studies on novel PCSK9 inhibitors as pharmacological approach for the treatment of Alzheimer’s disease 59
Relationship between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Human Macrophages 59
Relationship Between Cholesterol Accumulation and Cellular Senescence in an In Vitro Model of Vascular Cells 58
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD 58
“PCSK9 inhibition as potential strategy to treat Alzheimer’s disease: in vitro and in vivo studies” 57
“Studi in vitro e in vivo per lo sviluppo di nuovi inibitori di PCSK9 come strategia terapeutica nella malattia di Alzheimer” 50
Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis 43
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease 43
“Probing the efficacy of natural and novel synthetic PCSK9 inhibitors in reducing neuroinlfammation, Aβ-induced neurotoxicity and modulating cholesterol uptake in human cerebral cell models” 42
“Proprotein convertase subtilisin/kexin type 9 and plasma/cerebrospinal fluid lipids in patients with cognitive decline” 40
RELATIONSHIP BETWEEN CHOLESTEROL ACCUMULATION AND CELLULAR SENESCENCE IN AN IN VITRO MODEL OF HUMAN MACROPHAGE: POTENTIAL PROTECTIVE EFFECTS OF RESVERATROL 39
Optimization of 4‐Amino‐2‐Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure–Activity and Structure–Metabolism Relationships 22
Development of Novel PCSK9 Inhibitors as Potential Broad-Spectrum Antivirals 11
Influence of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) on brain cholesterol metabolism and potential impact on Alzheimer's Disease pathogenesis 8
Totale 4.962
Categoria #
all - tutte 17.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 0 0 7 2 3 9 7 5 0 0 0 14
2022/2023318 16 23 16 22 44 23 14 23 104 15 16 2
2023/2024367 27 27 14 14 13 42 38 35 22 14 32 89
2024/2025908 32 38 57 78 73 84 90 50 82 81 89 154
2025/20263.003 212 320 331 208 368 178 270 192 355 262 217 90
2026/2027282 166 116 0 0 0 0 0 0 0 0 0 0
Totale 4.962